Sunshine Biopharma (SBFM) Asset Utilization Ratio (2018 - 2026)

Sunshine Biopharma's Asset Utilization Ratio history runs 9 years deep, the most recent figure standing at 1.22 for Q1 2026.

• Quarterly Asset Utilization Ratio rose 0.89% year-over-year to 1.22 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.22 (up 0.89% YoY) and the FY2025 annual result came in at 1.2, down 0.59% from the prior year.
• Asset Utilization Ratio was 1.22 for Q1 2026 at Sunshine Biopharma, up from 1.18 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 1.22 in Q1 2026 and bottomed at 0.01 in Q3 2022.
• A 5-year average of 0.75 and a median of 0.9 in 2024 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio sank 85.06% — and 2023, when it soared 6027.84%.
• Sunshine Biopharma's Asset Utilization Ratio stood at 0.12 in 2022, then surged by 606.75% to 0.88 in 2023, then soared by 31.33% to 1.15 in 2024, then grew by 2.5% to 1.18 in 2025, then rose by 3.76% to 1.22 in 2026.
• Business Quant data shows SBFM's Asset Utilization Ratio at 1.22 in Q1 2026, 1.18 in Q4 2025, and 1.18 in Q3 2025.